| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 2.103 | 16.945 | 1.284 | 0 | 0 | 0 |
| Total Income - EUR | - | - | - | - | 2.220 | 28.967 | 3.618 | 2.341 | 2.334 | 2.321 |
| Total Expenses - EUR | - | - | - | - | 3.000 | 24.183 | 3.385 | 2.341 | 2.334 | 2.321 |
| Gross Profit/Loss - EUR | - | - | - | - | -780 | 4.783 | 233 | 0 | 0 | 0 |
| Net Profit/Loss - EUR | - | - | - | - | -780 | 4.652 | 194 | 0 | 0 | 0 |
| Employees | - | - | - | - | 1 | 1 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Saltherapy Mmxix S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 4.387 | 17.054 | 14.341 | 12.044 | 9.674 | 7.298 |
| Current Assets | - | - | - | - | 32.721 | 5.512 | 4.045 | 4.057 | 4.045 | 4.022 |
| Inventories | - | - | - | - | 7.481 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 9.395 | 949 | 0 | 3.995 | 3.983 | 3.960 |
| Cash | - | - | - | - | 15.844 | 4.563 | 4.045 | 62 | 62 | 62 |
| Shareholders Funds | - | - | - | - | -738 | 3.928 | 4.035 | 4.048 | 4.035 | 4.013 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 2.483 | 1.601 | 25 | 26 | 25 | 25 |
| Income in Advance | - | - | - | - | 35.362 | 17.037 | 14.325 | 12.028 | 9.658 | 7.282 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Saltherapy Mmxix S.r.l.